Brief: SeQuent Scientific Gets Suitability Certificate For Its Generic API Diclazuril In The EU
Jan 28 (Reuters) - SeQuent Scientific Ltd SEQU.NS :
* GOT ‘CERTIFICATE OF SUITABILITY’ FOR ITS GENERIC API
DICLAZURIL
IN THE EU
Source text: (https://bit.ly/3ojJYAg)
Further company coverage: SEQU.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India